mTOR-mediated phosphorylation of VAMP8 and SCFD1 regulates autophagosome maturation

Hong Huang1,2,3,4, Qinqin Ouyang1,2,3,4, Min Zhu5

  • 1College of Food Science and Technology, Nanjing Agricultural University, Nanjing, China.

Nature Communications
|November 17, 2021
PubMed

Insights

Mammalian target of rapamycin (mTORC1) controls autophagy by phosphorylating VAMP8, inhibiting autophagosome-lysosome fusion. This blocks SNARE complex formation and SCFD1 recruitment, impacting cellular waste clearance.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Autophagy Research

Background:

  • The mammalian target of rapamycin (mTORC1) pathway is a key regulator of cellular processes, including autophagy.
  • Autophagy is crucial for cellular homeostasis, involving the degradation of damaged components via autolysosomes.
  • The precise mechanisms by which mTORC1 influences autophagosome-lysosome fusion, particularly concerning SNARE complex regulation, are not fully understood.

Purpose of the Study:

  • To elucidate the role of mTORC1 in regulating the N-ethylmaleimide-sensitive protein receptor (SNARE) complex during autophagy.
  • To investigate how mTORC1-mediated signaling affects the formation of the STX17-SNAP29-VAMP8 SNARE complex.
  • To determine the impact of VAMP8 phosphorylation on autophagosome-lysosome fusion and related cellular processes.

Main Methods:

  • Phosphorylation analysis of VAMP8 by mTORC1.
  • In vitro assays using VAMP8 phosphorylation mimic mutants to assess autophagosome-lysosome fusion.
  • Identification and characterization of SCFD1's role in SNARE complex formation and autophagosome-lysosome fusion.
  • Assessment of VAMP8 dephosphorylation-dependent SCFD1 recruitment to autolysosomes.
  • In vivo studies using mouse liver models to evaluate the physiological consequences of VAMP8 phosphorylation.

Main Results:

  • mTORC1 directly inhibits the formation of the STX17-SNAP29-VAMP8 SNARE complex by phosphorylating VAMP8.
  • Phosphorylation of VAMP8 by mTORC1 prevents autophagosome-lysosome fusion.
  • A phosphorylation mimic mutant of VAMP8 failed to promote autophagosome-lysosome fusion in vitro.
  • SCFD1, a Sec1/Munc18-like protein, is identified as essential for SNARE complex assembly and autophagosome-lysosome fusion at the autolysosome.
  • Dephosphorylated VAMP8 facilitates SCFD1 recruitment to autolysosomes, promoting fusion; conversely, phosphorylated VAMP8 or SCFD1 depletion inhibits fusion.
  • Expression of phosphomimic VAMP8 in mouse liver led to increased lipid droplet accumulation, suggesting impaired autophagy.

Conclusions:

  • mTORC1-mediated phosphorylation of VAMP8 serves as a critical inhibitory mechanism for autophagosome-lysosome fusion.
  • The phosphorylation status of VAMP8 dictates its interaction with SCFD1, thereby controlling SNARE complex formation and fusion progression.
  • This regulatory axis highlights a novel link between mTORC1 signaling and the machinery governing autophagosome-lysosome fusion, with implications for cellular lipid metabolism.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.9K